Overview

Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, placebo-controlled trial into the safety and efficacy in reducing clinical measures of aging in an older adult population.
Phase:
Phase 2
Details
Lead Sponsor:
AgelessRx
Collaborator:
University of California, Los Angeles
Treatments:
Sirolimus